RecruitingNCT04529798

Clinical Study Evaluating Outcomes of Reverse Shoulder Arthroplasty With SMR Stemless

A Monocentric Clinical Study Evaluating Clinical and Patient-reported Outcomes of Reverse Shoulder Arthroplasty With SMR Stemless


Sponsor

Arthro Medics AG

Enrollment

60 participants

Start Date

Nov 22, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

The objectives of this study are the assessment of the clinical, radiographical and patient-reported outcomes of SMR Stemless Reverse Shoulder Arthroplasty (LimaCorporate S.p.A.) used as standard of care over a period of at least 2 years of follow-up and the evaluation of the incidence of any complication.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • rotator-cuff arthropathy, osteoarthritis
  • approving written informed consent

Exclusion Criteria3

  • Female patients who are pregnant, nursing, or planning a pregnancy.
  • All adult patients with any of the SMR Stemless contraindication for use for the reverse configuration as reported in the current local Instruction for use.
  • not consenting in participating in this study

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Arthro Medics AG

Basel, Canton of Basel-City, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04529798


Related Trials